Synonyms
Historical Background
Up to date, there are 14 different subtypes of 5-HT receptors (5-HTR) discovered and they are divided into seven major classes (5-HT1 to 5-HT7). All these receptors are G protein-coupled receptors (GPCRs), except for 5-HT3 that is a part of the Cys-loop superfamily of ligand-gated ion channels (LGICs). 5-HT1 class (composed by 5 subtypes – 5-HT1a-f) is coupled with a Gi/o protein, which inhibits adenylate cyclase (AC) activity and modulates calcium and potassium channels; 5-HT2 class (composed by 3 subtypes – 5-HT2a-c) is coupled with a Gq protein, which activates the phospholipase C pathways and releases inositol triphosphate (IP3) and diacylglycerol (DAG). The last group is composed by 5-HT4 to 5HT7 receptors and they are all Gs coupled; therefore, their activation regulates positively the function of AC (Marazziti et al. 2013).
5-HT6was first found in NCB-20 cells in 1979 by MacDermont and coworkers, but its...
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Bruin MNWJ, McCreary AC, van Loevezijn A, de Vries TJ, Venhorst J, Drimmelen M, et al. A novel highly selective 5-HT6 receptor antagonist attenuates ethanol and nicotine seeking but does not affect inhibitory response control in Wistar rats. Behav Brain Res. 2013;236:157–65. https://doi.org/10.1016/j.bbr.2012.08.048.
Codony X, Vela JM, Ramírez MJ. 5-HT6 receptor and cognition. Curr Opin Pharmacol. 2011;11(1):94–100. https://doi.org/10.1016/j.coph.2011.01.004.
Di Chiara G, Valentini V, Fenu S. Behavioral and neurochemical pharmacology of 5-ht6 receptors related to reward and reinforcement. In: Borsini F, editor. International review of neurobiology, Pharmacology of 5-HT6 receptors, part II, vol. 96; 2011. p. 111–39. https://doi.org/10.1016/B978-0-12-385902-0.00005-X.
Heal DJ, Smith SL, Fisas A, Codony X, Buschmann H. Selective 5-HT6 receptor ligands: progress in the development of a novel pharmacological approach to the treatment of obesity and related metabolic disorders. Pharmacol Ther. 2008;117(2):207–31. https://doi.org/10.1016/j.pharmthera.2007.08.006.
Helboe L, Egebjerg J, De Jong IEM. Distribution of serotonin receptor 5-HT6 mRNA in rat neuronal subpopulations: a double in situ hybridization study. Neuroscience. 2015;310:442–54. https://doi.org/10.1016/j.neuroscience.2015.09.064.
Hirst WD, Abrahamsen B, Blaney FE, Calver AR, Aloj L, Price GW, et al. Differences in the central nervous system distribution and pharmacology of the mouse 5- hydroxytryptamine-6 receptor compared with rat and human receptors investigated by radioligand binding, site-directed mutagenesis, and molecular modeling. Mol Pharmacol. 2003;64(6):1295–308. https://doi.org/10.1124/mol.64.6.1295.
Karila D, Freret T, Bouet V, Boulouard M, Dallemagne P, Rochais C. Therapeutic potential of 5-HT 6 receptor agonists. J Med Chem. 2015;58(20):7901–12. https://doi.org/10.1021/acs.jmedchem.5b00179.
Knudsen GM, Hasselbalch SG. Imaging of the serotonin system: radiotracers and applications in memory disorders. In: Dierckx RAJO, Otte A, de Vries EFJ, van Waarde A, Luiten PGM, editors. PET and SPECT of neurobiological systems. Berlin/Heidelberg: Springer; 2014. p. 669–86. https://doi.org/10.1007/978-3-642-42014-6_23.
Marazziti D, Baroni S, Borsini F, Picchetti M, Vatteroni E, Falaschi V, et al. Serotonin receptors of type 6 (5-HT6): from neuroscience to clinical pharmacology. Curr Med Chem. 2013;20:371–7. https://doi.org/10.2174/0929867311320030008.
Messina D, Annesi G, Serra P, Nicoletti G, Pasqua A, Annesi F, et al. Association of the 5-HT6 receptor gene polymorphism C267T with Parkinson’s disease. Neurology. 2002;58(5):828–9. https://doi.org/10.1212/WNL.58.5.828.
Monsma F, Shen Y, Ward RP, Hamblin MW, Sibley DR. Cloning and expression of a novel serotonin receptor with affinity for tricyclic psychotropic drugs. Mol Pharmacol. 1993;43(3):320–7.
Müller CP, Pum ME, Schumann G, Huston JP. The role of serotonin in drug addiction. In: Müller CP, Jacobs BL, editors. Handbook of behavioral neuroscience, vol. 21; 2010. p. 507–45. https://doi.org/10.1016/S1569-7339(10)70099-0.
Pereira M, Martynhak BJ, Andreatini R, Svenningsson P. 5-HT6 receptor agonism facilitates emotional learning. Front Pharmacol. 2015;16(6):200. https://doi.org/10.3389/fphar.2015.00200.
Roth BL, Craigo SC, Choudhary MS, Uluer A, Monsma Jr FJ, Shen Y, et al. Binding of typical and atypical antipsychotic agents to 5- hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors. J Pharmacol Exp Ther. 1994;268(3):1403–10.
Ruat M, Traiffort E, Arrang JM, Tardivel-Lacombe J, Diaz J, Leurs R, et al. A novel rat serotonin (5-HT6) receptor: molecular cloning localization and stimulation of cAMP. Biochem Biophys Res Commun. 1993;193(1):268–76. https://doi.org/10.1006/bbrc.1993.1619.
Schechter LE, Lin Q, Smith DL, Zhang G, Shan Q, Platt B, et al. Neuropharmacological profile of novel and selective 5-HT6 receptor agonists: WAY-181187 and WAY-208466. Neuropsychopharmacology. 2008;33(6):1323–5. https://doi.org/10.1038/sj.npp.1301503.
Tsai SJ, Liu HC, Liu TY, Wang YC, Hong CJ. Association analysis of the 5-HT6 receptor polymorphism C267T in Alzheimer’s disease. Neurosci Lett. 1999;276(2):138–9.
Usworth C, Molinoff P. Characterization of a 5-hyroxytyptamine receptor in mouse neuroblastoma N18TG2 cells. J Pharmacol Exp Ther. 1994;269:245–55. https://doi.org/10.1016/j.ejphar.2011.03.020.
Woods S, Clarke NN, Layfield R, Fone KC. 5-HT(6) receptor agonists and antagonists enhance learning and memory in a conditioned emotion response paradigm by modulation of cholinergic and glutamatergic mechanisms. Br J Pharmacol. 2012;167(2):436–49. https://doi.org/10.1111/j.1476-5381.2012.02022.x.
Woolley ML, Bentley JC, Sleight AJ, Marsden CA, Fone KC. A role for 5-ht6 receptors in retention of spatial learning in the Morris water maze. Neuropharmacology. 2001;41(2):210–9. https://doi.org/10.1016/S0028-3908(01)00056-9.
Acknowledgment
Author financial support: CAPES (Coordination for the Improvement of Higher Education Personnel).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this entry
Cite this entry
Pereira, M. (2018). 5-Hydroxytryptamine Receptor 6. In: Choi, S. (eds) Encyclopedia of Signaling Molecules. Springer, Cham. https://doi.org/10.1007/978-3-319-67199-4_101490
Download citation
DOI: https://doi.org/10.1007/978-3-319-67199-4_101490
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-67198-7
Online ISBN: 978-3-319-67199-4
eBook Packages: Biomedical and Life SciencesReference Module Biomedical and Life Sciences